Provider
Kerendia - Commercial
Step Therapy, Quantity Limit
Program effective Date: Mar 01, 2026
Documents & Forms Results
Displaying 3561 - 3570 of 3622 results
Provider
Otezla (apremilast) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Oxybate - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Ohtuvayre - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Interleukin-31 (IL-31) Inhibitor - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Journavx - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Presbyopia Agents - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Pain Medications - Commercial
Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Pseudobulbar Affect (PBA) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Provider
Somatostatin Analogs - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026